Discover 1,170 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,170
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Montreal, Greenfield Park, Trois-Rivieres, Sherbrooke,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT07028853
Phase3, Recruiting
Implementation of Support in the Care of Adults Living With Type 1 Diabetes
for
Type 1 Diabetes, Metabolic Disease, Endocrine System Diseases,
Location: Montreal, Terrebonne, Quebec
Sponsor: McGill University
Sex: All
Age: 18+
Code: NCT06069583
Recruiting
Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
for
Malignant Neoplasm
Location: Montreal, San Antonio TX
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07600749
Phase1, Recruiting
Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
for
Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer,
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18+
Code: NCT07180901
Recruiting
Sensory Anesthesia Achieved Through Different Paravertebral Block Approaches for Post-Op Pain Management After VATS Lung Resection
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18 - 55
Code: NCT06788587
Phase2, Recruiting
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
for
Colitis Ulcerative, Ulcerative Colitis
Location: Montreal, Macon GA, Liberty MO, Kansas City KS,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07463183
Phase2, Recruiting
AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
for
Idiopathic Pulmonary Fibrosis (IPF)
Location: Montreal, Trois-Rivieres, Ajax, Halifax, St. John's,
Sponsor: Avalyn Pharma Inc.
Sex: All
Age: 40+
Code: NCT07194382
Phase2, Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for
Endometrial Cancer
Location: Montreal, Sherbrooke, Scarborough ME, Boston MA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06952504
Phase3, Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)